Literature DB >> 16799310

An alternative dressing material for the split-thickness skin graft donor site: oxidized regenerated cellulose.

A Cagri Uysal1, M Sahin Alagoz, Hakan Orbay, Omer Sensoz.   

Abstract

The split-thickness skin graft (STSG) donor sites have been treated with various and plenty of dressing techniques and materials. An ideal STSG donor site dressing should have antibacterial, hemostatic, and promoting epidermal healing properties. We have performed a prospective study to evaluate the effect of the oxidized regenerated cellulose on STSG donor site healing. Between January 2002 and January 2005, 40 patients who were operated in any kind of reconstructive operations with STSG donor sites were included in the study. One half of the wound was covered with oxidized regenerated cellulose and the other half of the same wound of the same patient was covered with fine mesh gauze treated with Furacin (nitrofurazone). The patients were grouped into 2 depending on the dressing technique: group I, semiclosed and group II, closed. The wounds were evaluated for healing time, infection, pain perception of the patient, and final esthetic results. The oxidized regenerated cellulose side of the group I was healed in a mean of 6.5 +/- 0.51 days; in group II, 5.4 +/- 0.50 days (range, 5-6 days). The fine mesh gauze treated with Furacin in group I was healed in a mean of 9.9 +/- 0.97 days (range, 8-11 days); in group II, 8.4 +/- 0.99 days (range, 7-10 days). There was a statistical significance between the oxidized regenerated cellulose side and the fine mesh gauze side (P < 0.001) in group I and group II separately. The difference between group I and group II was statistically significant in the oxidized regenerated cellulose side (P < 0.001), and the difference between group I and group II was statistically significant in the fine mesh gauze side (P < 0.005). The antibacterial, hemostatic, and absorbable property of the oxidized regenerated cellulose could ensure the utilization as an alternative STSG donor site dressing, especially because the positive influence over the wound healing was proven.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16799310     DOI: 10.1097/01.sap.0000208945.12083.59

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  7 in total

1.  Effectiveness of collagen/oxidised regenerated cellulose/silver-containing composite wound dressing for the treatment of medium-depth split-thickness skin graft donor site wounds in multi-morbid patients: a prospective, non-comparative, single-centre study.

Authors:  Alexander Konstantinow; Tatjana V Fischer; Johannes Ring
Journal:  Int Wound J       Date:  2016-12-01       Impact factor: 3.315

2.  Microcrystalline cellulose membrane for re-epithelisation of chronic leg wounds: a prospective open study.

Authors:  Elia B Ricci; Roberto Cassino; Cristiana Di Campli
Journal:  Int Wound J       Date:  2010-12       Impact factor: 3.315

3.  An evidence-based review of split-thickness skin graft donor site dressings.

Authors:  Julie E Brown; Samantha L Holloway
Journal:  Int Wound J       Date:  2018-08-17       Impact factor: 3.315

4.  Evaluation of Amniotic Membrane Effectiveness in Skin Graft Donor Site Dressing in Burn Patients.

Authors:  Seyed Hamid Salehi; Kamran As'adi; Seyed Jaber Mousavi; Saeed Shoar
Journal:  Indian J Surg       Date:  2013-01-31       Impact factor: 0.656

5.  Comparative clinical study of Bactigras and Telfa AMD for skin graft donor-site dressing.

Authors:  Pornprom Muangman; Sooksan Nitimonton; Pornanong Aramwit
Journal:  Int J Mol Sci       Date:  2011-08-08       Impact factor: 5.923

6.  Immediate Regrafting of the Split Thickness Skin Graft Donor Site Assists Healing.

Authors:  Brian P Bradow; Geoffrey G Hallock; Samuel P Wilcock
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-05-23

7.  Associated use of silicone-vitamin E gauzes and α-tocopherol acetate oil in healing of skin graft donor sites.

Authors:  Antonio Stanizzi; Manuela Bottoni; Caterina Tartaglione; Elisa Bolletta; Giovanni Di Benedetto
Journal:  Int Wound J       Date:  2017-01-23       Impact factor: 3.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.